News

News

Team Announcement

Tower Mains is pleased to welcome Victoria Macleod to the team as Administrative Associate. Victoria has experience working in clinical and event/hospitality settings, and a degree in History of Art and [...]

17-February-2021|Blog|

Announcement

Tower Mains is pleased to announce two important appointments as part of our strategic growth. Cate Ovington has been appointed as the Head of Quality Management and Shona Ross as [...]

01-February-2021|Blog|

Pharma News Update January 2021

COVID-19 Vaccine Development Moderna COVID-19 Vaccine Has Neutralising Activity Against Emerging Virus Variants On 25th January 2021, Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced results [...]

28-January-2021|Pharma News|

Pharma News Update December 2020

COVID-19 Vaccine Development Russia’s COVID-19 Vaccine Data Shows 91.4% Efficacy Rate On 14th December 2020, Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine [...]

18-December-2020|Pharma News|

Regulatory News Update November 2020

Medicines and Healthcare products Regulatory Agency (MHRA) MHRA draft guidance on randomised controlled trials generating real-world evidence to support regulatory decisions A draft guidance on randomized controlled trials generating real-world [...]

30-November-2020|Regulatory News|

Pharma News Update November 2020

COVID-19 Vaccine Development Oxford University and AstraZeneca’s AZD1222 Vaccine Meets Primary Efficacy Endpoint in Preventing COVID-19 On 23rd November 2020, AstraZeneca announced positive high-level results from an interim analysis of [...]

26-November-2020|Pharma News|

Categories